Evidence map›Paper›PMID 26149011›Full record

ReviewJournal of thrombosis and haemostasis : JTH2015

Pathogen activators of plasminogen.

I M Verhamme, P R Panizzi, P E Bock

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of thrombosis and haemostasis : JTH, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Frontiers in microbiology · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Frontiers in immunology · 2019
    Article
  10. Proteases: Pivot Points in Functional Proteomics.Methods in molecular biology (Clifton, N.J.) · 2019
    Review
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

I M VerhammeDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
P R PanizziDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
P E BockDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Vanderbilt University · USAuburn University · US

Funding

MOLECULAR MECHANISMS OF FIBRINOLYSISR01HL056181 · NHLBI · VANDERBILT UNIVERSITY · PI BOCK, PAUL E · 1996 to 2013
$3.9M
Mechanism of Staphylocoagulase-activated Blood ClottingR01HL071544 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOCK, PAUL E, VERHAMME, INGRID M · 2003 to 2016
$1.8M
NHLBI NIH HHS R01 HL056181NHLBI NIH HHS R01HL056181NHLBI NIH HHS R01 HL071544NHLBI NIH HHS R01HL071544
6 · The paper itself

Abstract

Group A streptococci (GAS) express soluble and surface-bound virulence factors. Secreted streptokinase (SK) allelic variants exhibit varying abilities to activate host plasminogen (Pg), and GAS pathogenicity is associated with Pg activation and localization of the resulting plasmin (Pm) on the bacterial surface to promote dissemination. The various mechanisms by which GAS usurp the host proteolytic system are discussed, including the molecular sexuality mechanism of conformational activation of the Pg zymogen (Pg*) and subsequent proteolytic activation of substrate Pg by the S•KPg* and SK•Pm catalytic complexes. Substantial progress has been made to delineate both processes in a unified mechanism. Pm coats the bacteria by direct and indirect binding pathways involving plasminogen-binding group A streptococcal M-like (PAM) protein and host fibrin(ogen). Transgenic mouse models using human Pg are being optimized to mimic infections by SK variants in humans and to define in vivo combined mechanisms of these variants and PAM.

Indexed as

FibrinolysisAnimalsBacterial ProteinsCarrier ProteinsFibrinFibrinolysinHost-Pathogen InteractionsHumansModels, MolecularPlasminogenProtein BindingStreptococcal InfectionsStreptococcus pyogenesStreptokinaseVirulenceVirulence FactorsBacterial ProteinsCarrier ProteinsFibrinFibrinolysinPlasminogenplasminogen-binding protein, bacteriaStreptokinaseVirulence Factorsenzymologyfibrinolysisplasminogenstreptococcusstreptokinase

Identifiers

PMID26149011
PMCPMC4498406
OpenAlexW1874187424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.